نتائج البحث

VEPTP inhibition with an extracellular domain targeting antibody did not restore albuminuria in a mouse model of diabetic kidney disease.

• Authors : Rana R; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Spring House, Pennsylvania, USA.; Cardiovascular and Metabolism, Johnson & Johnson Research & Development, Cambridge, Massachusetts, USA.

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Albuminuria*/Albuminuria*/Albuminuria*/metabolism

• Source: Physiological reports [Physiol Rep] 2024 Sep; Vol. 12 (18), pp. e70058.Publisher: published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society Country of Publication: United States NLM

تفاصيل العنوان

External validation and calibration of risk equations for prediction of diabetic kidney diseases among patients with type 2 diabetes in Taiwan.

• Authors : Su HY; Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, 1 University Road, Tainan, 701, Taiwan.; Nguyen TTD

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/diagnosis

• Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Oct 09; Vol. 23 (1), pp. 357. Date of Electronic Publication: 2024 Oct 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

Genetic deletion of calcium-independent phospholipase A2γ protects mice from diabetic nephropathy.

• Authors : Cybulsky AV; Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.; Papillon J

Subjects: Albuminuria*/Albuminuria*/Albuminuria*/genetics ; Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/complications ; Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/metabolism

• Source: PloS one [PLoS One] 2024 Oct 31; Vol. 19 (10), pp. e0311404. Date of Electronic Publication: 2024 Oct 31 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia.

• Authors : Kovacevic S; Endocrinology Department, University Children's Hospital, Belgrade, Serbia.; Zdravkovic V

Subjects: Methylenetetrahydrofolate Reductase (NADPH2)*/Methylenetetrahydrofolate Reductase (NADPH2)*/Methylenetetrahydrofolate Reductase (NADPH2)*/genetics ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/genetics ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/complications

• Source: PloS one [PLoS One] 2024 Oct 24; Vol. 19 (10), pp. e0312489. Date of Electronic Publication: 2024 Oct 24 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Trajectories of eGFR and risk of albuminuria in youth with type 2 diabetes: results from the TODAY cohort study.

• Authors : El Ghormli L; Wen H ...

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/diagnosis ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/epidemiology

• Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Dec; Vol. 38 (12), pp. 4137-4144. Date of Electronic Publication: 2023 Jul 11.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Diabetic Kidney Disease Without Albuminuria: A New Entity in Diabetic Nephropathy.

• Authors : Ahmadi N; Amouzegar A; Firoozgar Clinical Research Development Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. .

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/diagnosis ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/etiology ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy

• Source: Iranian journal of kidney diseases [Iran J Kidney Dis] 2024 Jan; Vol. 1 (1), pp. 1-8.Publisher: Iranian Society of Nephrology Country of Publication: Iran NLM ID: 101316967 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease.

• Authors : Llàcer, Pau^1,2 (AUTHOR) ; Marcos, Marta Cobo^3,4 (AUTHOR); de la Espriella, Rafael⁵ (AUTHOR)

• Source: Clinical Kidney Journal. Jun2024, Vol. 17 Issue 6, p1-10. 10p.

تفاصيل العنوان

Associations of the TyG index with albuminuria and chronic kidney disease in patients with type 2 diabetes.

• Authors : Li, Xiaonan¹ (AUTHOR); Wang, Yuehui¹ (AUTHOR)

Subjects: *TYPE 2 diabetes; *CHRONIC kidney failure; *KIDNEY diseases

• Source: PLoS ONE. 10/28/2024, Vol. 19 Issue 10, p1-13. 13p.

تفاصيل العنوان

Renoprotective potential of concomittant medications with SGLT2 inhibitors and renin-angiotensin system inhibitors in diabetic nephropathy without albuminuria: a retrospective cohort study.

• Authors : Ishibashi T; First Department of Medicine, Wakayama Medical University, 811‑1 Kimi‑idera, Wakayama City, Wakayama, 641‑8509, Japan. .; Morita S

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology

• Source: Scientific reports [Sci Rep] 2023 Sep 29; Vol. 13 (1), pp. 16373. Date of Electronic Publication: 2023 Sep 29.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Sirt6 ameliorates high glucose-induced podocyte cytoskeleton remodeling via the PI3K/AKT signaling pathway.

• Authors : Zhang Z; Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.; Huang H

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/pathology ; Sirtuins*/Sirtuins*/Sirtuins*/metabolism

• Source: Renal failure [Ren Fail] 2024 Dec; Vol. 46 (2), pp. 2410396. Date of Electronic Publication: 2024 Oct 08.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان